SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096189
Filing Date
2024-08-13
Accepted
2024-08-13 16:08:22
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krro-20240630.htm   iXBRL 10-Q 2324788
2 EX-31.1 krro-ex31_1.htm EX-31.1 17331
3 EX-31.2 krro-ex31_2.htm EX-31.2 17213
4 EX-32.1 krro-ex32_1.htm EX-32.1 9447
  Complete submission text file 0000950170-24-096189.txt   8405412

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20240630.xsd EX-101.SCH 1395617
76 EXTRACTED XBRL INSTANCE DOCUMENT krro-20240630_htm.xml XML 1141964
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 241201450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)